These interesting findings showed that knowledge of the ACE2 gene regulatory network is important in revealing potential genetic drivers in ACE2-dependent renal function, the results of which are useful for the diagnosis and treatment of renal cancer patients with COVID-19 complications. This evidence concerns the gene ACE2 and renal carcinoma.